 DUBLIN, Ireland and TREVOSE, Pa., Oct. 05, 2021 GLOBE NEWSWIRE -- Strongbridge Biopharma plc NASDAQ: SBBP the Company or Strongbridge today announced that the High Court of Ireland the Court has approved the previously announced proposed acquisition of Strongbridge by Xeris Pharmaceuticals, Inc. Nasdaq: XERS Xeris by means of a scheme of arrangement the Scheme under Chapter 1 of Part 9 of the Irish Companies Act 2014 the Act. 